I agree that this site is using cookies. You can find further informations here.
X
Thomas, Sharyn
167  results:
Search for persons X
?
1

Exploitation of CD3ζ to enhance TCR expression levels and a..:

Degirmencay, Abdullah ; Thomas, Sharyn ; Holler, Angelika...
Frontiers in Immunology.  15 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
2

Modifications outside CDR1, 2 and 3 of the TCR variable β d..:

Degirmencay, Abdullah ; Thomas, Sharyn ; Mohammed, Fiyaz..
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
3

Forced Fox-P3 expression can improve the safety and antigen..:

McGovern, Jenny ; Holler, Angelika ; Thomas, Sharyn.
Journal of Autoimmunity.  132 (2022)  - p. 102888 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Framework engineering to produce dominant T cell receptors ..:

Thomas, Sharyn ; Mohammed, Fiyaz ; Reijmers, Rogier M....
Nature Communications.  10 (2019)  1 - p. , 2019
Link: https://doi.org/10.1038/..
 
?
5

Crispr/Cas Mediated Deletion of PTPN22 in Jurkat T Cells En..:

Bray, Cara ; Wright, David ; Haupt, Sonja...
Frontiers in Immunology.  9 (2018)  - p. , 2018
Link: https://doi.org/10.3389/..
 
?
6

Human MHC Class I-restricted high avidity CD4+T cells gener..:

Xue, Shao-An ; Gao, Liquan ; Ahmadi, Maryam...
OncoImmunology.  2 (2013)  1 - p. e22590 , 2013
Link: https://doi.org/10.4161/..
 
?
7

Molecular immunology lessons from therapeutic T‐cell recept..:

Thomas, Sharyn ; Stauss, Hans J. ; Morris, Emma C.
Immunology.  129 (2010)  2 - p. 170-177 , 2010
Link: https://doi.org/10.1111/..
 
?
8

WT1-specific T cell receptor gene therapy: Improving TCR fu..:

Stauss, Hans J. ; Thomas, Sharyn ; Cesco-Gaspere, Michela...
Blood Cells, Molecules, and Diseases.  40 (2008)  1 - p. 113-116 , 2008
Link: https://doi.org/10.1016/..
 
?
9

Monoclonal T-Cell Receptors: New Reagents for Cancer Therap:

Stauss, Hans J ; Cesco-Gaspere, Michela ; Thomas, Sharyn...
Molecular Therapy.  15 (2007)  10 - p. 1744-1750 , 2007
Link: https://doi.org/10.1038/..
 
?
10

Polyvalent dendrimer glucosamine conjugates prevent scar ti..:

Shaunak, Sunil ; Thomas, Sharyn ; Gianasi, Elisabetta...
Nature Biotechnology.  22 (2004)  8 - p. 977-984 , 2004
Link: https://doi.org/10.1038/..
 
?
11

Modifications outside CDR1, 2 and 3 of the TCR variable β d..:

Degirmencay, Abdullah ; Thomas, Sharyn ; Mohammed, Fiyaz..
https://discovery.ucl.ac.uk/id/eprint/10169308/1/fimmu-14-1148890.pdf.  , 2023
Link: https://discovery.ucl.ac..
 
?
12

Modifications outside CDR1, 2 and 3 of the TCR variable β d..:

Degirmencay, Abdullah ; Thomas, Sharyn ; Mohammed, Fiyaz..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134071/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
13

Framework engineering to produce dominant T cell receptors ..:

Thomas, Sharyn ; Mohammed, Fiyaz ; Reijmers, Rogier M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773850/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
14

Crispr/Cas Mediated Deletion of PTPN22 in Jurkat T Cells En..:

Bray, Cara ; Wright, David ; Haupt, Sonja...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240618/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
15

Human MHC Class I-restricted high avidity CD4+ T cells gene..:

Xue, Shao-An ; Gao, Liquan ; Ahmadi, Maryam...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583927.  , 2013
Link: http://www.ncbi.nlm.nih...
 
1-15